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ABSTRACT
The study of polymer-protein nanoparticles is of increasing interest due to their various
potential applications in biosensing, imaging, bioseparations, gene and drug delivery, etc.
Synthetic polymers can be tailored with different functional groups and properties,
therefore, they can serve as platforms to impart proteins with additional features and assist
proteins to better perform biological functions. In this dissertation work, we were mainly
focusing on the preparation of polymer-protein core-shell nanoparticles by synthesizing
new functional polymers and assembling them with proteins for different applications.
In chapter 1, a pyridine grafted diblock copolymer P(CL-g-Py)-b-PCL was prepared
through ROP and CuAAC reactions. Core-shell nanoparticles (CSNPs) from the selfassembly of this polymer and transferrin (Tf) were characterized by dynamic light
scattering, transmission electron microscope and circular dichroism. As compared with
CSNPs prepared from homopolymer P4VP and Tf, these particles exhibited narrower size
distribution, improved particle stability, and higher loading capacity for anticancer drug
doxorubicin (DOX). Additionally, the drug loaded Tf/P(CL-g-Py)-b-PCL CSNPs can
effectively target MCF7 cancer cells via the binding of Tf to Tf receptors.
In chapter 2, we created the cellulase library. Three cellulases CelAt, CelGc, and CelF
were purified and assembled with pyridine grafted polymers to create cellulase anchored
CSNPs. The prepared CSNPs were characterized. The enzymatic activity of the
immobilized cellulases were compared with free enzymes. Contrary to our hypothesis,
vi

none of the single-enzyme or double-enzyme, or triple-enzyme assembly systems showed
obvious elevated enzyme activity as compared to free enzyme.
Based on the study in chapter 2, in chapter 3, we synthesized block copolymer PS-bPSMA through one-pot RAFT polymerization and modified the polymer with NTA groups.
The self-assembly of the polymer in the presence of Ni 2+ ions led to the formation of
nanoparticles of about 20 nm in aqueous solution. The NTANi complexes located on the
particle surface can capture 6× His-tagged proteins by strong affinity binding. The
conjugated proteins are within close proximity. The catalytic activity of cellulases was
elevated after being assembled with NTANi containing micelles due to the enhanced local
concentration and synergy effect.
In chapter 4, besides synthetic polymer, we are exploring virus bio-nanoparticles TMV
as a novel carrier for the immobilization of proteins. TMV has highly ordered architecture
and uniform shape. The coat proteins of TMV were modified with NTANi groups via
sequential diazonium-coupling and CuAAC reaction. The modified VNPs can be utilized
for constructing novel biomaterials through the specific interaction between NTANi
complexes and polyhistidine. Our current work employed two fluorescent proteins, eGFP
and mcherry, as model proteins to study the potential of TMV-NTANi for protein
immobilization. It was shown that eGFP and mcherry can be immobilized separately or
together on TMV surface. We believe that this method can be extended to other 6×histagged functional proteins.
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CHAPTER 1 DEVELOPMENT OF CORE-SHELL NANOSTRUCTURES BY IN SITU
ASSEMBLY OF PYRIDINE-GRAFTED DIBLOCK COPOLYMER AND
TRANSFERRIN FOR DRUG DELIVERY APPLICATIONS 1

1

Lu L., Yuan L., Yan J., Tang C., and Wang Q., Biomacromolecules, 2016, 17, 2321-2328.
Reprinted here with permission. Copyright (2016) American Chemical Society.
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1.1 INTRODUCTION

Recently, different polymer/protein nanostructures have been developed for applications
in bioseparations, catalysis, imaging, and drug delivery, etc.1-10 In general, polymers can
be endowed with different properties by introducing various functional groups in the
synthetic process, while proteins, with intrinsic hierarchical structures, can bring in their
biological functions. Methods of fabricating polymer/protein nanostructures include direct
conjugation and assembly,11-16 electrostatic assembly,17-21 physical adsorption,22-25 and
affinity binding26-28. In most situations, the interaction between polymers and proteins
influences the protein conformation and further affects their bioactivities because many
proteins are highly susceptible to unfolding and denaturation. For example, the loss in
protein and enzyme activities has been found in directed conjugation, electrostatic
assembly, and physical adsorption.21,

23, 29

Therefore, the preservation of protein

conformation and activity becomes more vital in constructing polymer/protein
nanostructures.

In our previous studies, we reported the fabrication of core-shell nanoparticles (CSNPs)
from the co-assembly of pyridine-grafted homopolymers poly(4-vinylpyridine) (P4VP)
and pyridine grafted poly(hydroxyethyl methacrylate) (PHEMA-Py) with various proteins
and protein nanoparticles.30-35 The co-assembly process is primarily entropically driven,
while the resultant CSNPs are stabilized by hydrogen bonding between proteins and
pyridine-grafted polymers. The pyridine groups can serve as an efficient acceptor to form
2

hydrogen bonds with the a variety of H-donors available from protein side chains.36-37
Similar to Pickering emulsions,1, 38-42 proteins displace the interface of water molecules
and polymers to minimize the interfacial energy and finally cover the surface of CSNPs.43
It has been shown that the fine balanced microenvironment between proteins and polymers
can not only help to retain the original protein conformation, but also promote protein
folding on the nanoparticle surface both in vitro and in vivo when compared with the
unassembled proteins.33, 35

Here, we report the preparation of CSNPs by the co-assembly of a pyridine-grafted
diblock copolymer poly(caprolactone-graft-pyridine)-block-poly(caprolactone) [P(CL-gPy)-b-PCL] and transferrin (Tf) (Scheme 1.1). The polymer P(CL-g-Py)-b-PCL was
synthesized through a combination of ring-opening polymerization (ROP) and Cu(I)
catalyzed azide-alkyne cycloaddition (CuAAC) reaction (Scheme 1.2).44-45 Superior to
homopolymer, this diblock copolymer has the P(CL-Py) block to immobilize Tf via
hydrogen bonding and the PCL block to load hydrophobic anticancer drugs. Human plasma
Tf was selected as a model protein since it has been widely used in drug delivery systems
as the targeting ligand for malignant cells overexpressing transferrin receptor (TfR).46
Unlike traditional covalent conjugation of Tf to drug delivery vehicles, 46 our non-covalent
strategy is more facile and milder, which helps maintaining the structure and function of
Tf. The Tf/P(CL-g-Py)-b-PCL CSNPs showed narrower range of particle sizes, improved
stability and loading capacity for anticancer drug DOX compared with those of Tf/P4VP.

3

The drug loaded Tf/P(CL-g-Py)-b-PCL/DOX CSNPs exhibited a targeting behavior to TfR
overexpressed MCF7 cancer cells. We believe this versatile method can be expanded to
similar pyridine-grafted block copolymers and other functional proteins for the purpose of
biomedical and bioengineering applications.
Scheme 1.1. Preparation of Tf/P(CL-g-Py)-b-PCL CSNPs and DOX loaded Tf/P(CL-gPy)-b-PCL CSNPs.

Scheme 1.2. Synthesis of block copolymer P(CL-g-Py)-b-PCL.
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1.2 MATERIALS AND METHODS

1.2.1. Materials. Holo-human transferrin (Sigma-Aldrich), poly(4-vinylpyridine) (P4VP,
Mw ~60000, Sigma-Aldrich), α-Chlorocyclohexanone (Alfa Aesar, 97%) , mchloroperoxybenzoic acid (mCPBA, Acros, 70-75%), sodium azide (Sigma-Aldrich,
99.5%), copper iodine (CuI, Sigma-Aldrich, 99.999%) , stannous octoate (Sigma-Aldrich,
92.5-100.0%), propargyl alcohol (Sigma-Aldrich, 99%), pyridine (Sigma-Aldrich,
anhydrous, 99.8%), nicotinoyl chloride hydrochloride (Sigma-Aldrich, 97%), 1,8diazabicyclo[5.4.0]undec-7-ene

(DBU,

Sigma-Aldrich,

98%),

and

ethylenediaminetetraacetic acid tetrasodium salt hydrate (EDTA, Sigma-Aldrich, 99.0%)
were used as received. 3-Chloro-1-propanol (Sigma-Aldrich, 98%) was vacuum distilled
and stored under vacuum prior to use. ε-Caprolactone (CL, Sigma-Aldrich, 99%) was dried
over CaH2 and vacuum distilled. Toluene was distilled over sodium/benzophenone and
stored under N2 before use. All other chemicals and solvents were purchased from
commercial resources and used as received. α-Chloro-ε-caprolactone (αClεCL) and
nicotinic propargyl ester were synthesized according to reported methods.47-48
1.2.2. Characterization. 1H NMR and

13

C NMR spectra were obtained on a Varian

Mercury 400 spectrometer with tetramethylsilane (TMS) as an internal reference. Size
exclusion chromatography (SEC) was used to determine molecular weight and molecular
weight distribution of polymers. The system was equipped with a 2414 RI detector, a 1525
Binary Pump and three Styragel columns. The columns consist of HR 1, HR 3 and HR 5E
5

with molecular weight in the range of 1×105 - 5×103 g/mol, 5×105 - 3×104 g/mol and 2×103
- 4×106 g/mol respectively. The eluent was tetrahydrofuran (THF) at 35 °C with a flow rate
of 1.0 mL/min. Polystyrene standards from Polymer laboratories were used for calibration.
The SEC samples were prepared by filtering a 3.0 mg/mL solution in THF through
microfilters with an average pore size of 200 nm. Fourier transform infrared spectrometry
(FT-IR) spectra were recorded on PerkinElmer spectrum 100 FT-IR spectrometer. The
hydrodynamic diameter, size distributions and zeta potential were measured with dynamic
light scattering (DLS, Zetasizer Nano ZS, Malvern Instruments). UV-vis measurement was
performed on Nanodrop 2000c with 10 mm path length. Transmission electron microscopy
(TEM) samples were prepared by depositing 20 μL aliquots of samples onto 300-mesh
carbon-coated copper grids for 2 min and observed with a Hitachi H-8000 transmission
electron microscope. Circular dichroism (CD) measurement was performed on a Jasco 815
spectrophotometer, using a quartz cuvette with a 10 mm path length, and scans were taken
from 190 to 260 nm at a rate of 100 nm·min−1 with a 1 nm step resolution and a 1 s response.
1.2.3. Synthesis of P(αClεCL)-b-PCL Diblock Copolymers. P(αClεCL)-b-PCL diblock
copolymers were prepared by sequential ring-opening polymerization of αClεCL and CL
in dry toluene. A typical example for the polymerization process was given as follows. 3Chloro-1-propanol (9.5 mg, 0.1 mmol, bp = 160 oC), stannous octoate (24.3 mg, 0.06
mmol) and αClεCL (0.70 g, 4.2 mmol) were added into a 25 mL Schlenk flask containing
7.0 mL dry toluene. The solution was degassed by three cycles of freeze-pump-thaw and
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refilled with N2 before putting into a preheated oil bath set at 118 °C. After polymerization
for 2.5 hr, a nearly full conversion of monomer αClεCL was confirmed through 1H NMR.
The flask was removed from the oil bath and cooled to room temperature. Freshly distilled
CL (2.28 g, 20 mmol) was added into the cooled solution using a syringe and the mixed
solution was stirred for 5 min while purging with N2. The flask was put into an oil bath at
110 °C to start the polymerization of CL. The polymerization proceeded for another 3 hr
when 50% conversion of CL was achieved. The copolymers were isolated by precipitating
from cold hexane and dried under vacuum overnight. The molecular weight of P(αClεCL)b-PCL was calculated to be Mn = 17.7 k. From SEC characterization, Mn was determined
to be 18.1 k with polydispersity index Ð = 1.39. 1H NMR (CDCl3, ppm): 4.27 (t, CHClCOOCH2-), 4.17 (t, -CHClCOOCH2-), 4.05 (t, -CH2COOCH2-), 2.27 (t, CH2COOCH2-), 2.00 (m, -CHClCH2-), 1.82-1.25 (broad, -CH2CH2CH2- and CHClCH2CH2-).
1.2.4. Synthesis of P(αN3εCL)-b-PCL Diblock Copolymers. The chloro groups in
P(αClεCL)-b-PCL were replaced by azide groups through a nucleophilic substitution
process. P(αClεCL)-b-PCL (0.8 g, 1.8 mmol -Cl) was dissolved in 10.0 mL N,NDimethylformamide (DMF) with 2 drops of water, to which NaN3 (1.2 g, 18 mmol) was
added. The reaction was stirred at 30 °C for 24 hr. The final solution was diluted with 40
mL DCM and centrifuged to remove insoluble salts. The organic phase was washed with
brine solution (100 mL) 3 times via gentle stirring in a beaker to remove DMF and
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remaining NaN3. The DCM polymer solution was dried over anhydrous MgSO4,
centrifuged and concentrated under reduced pressure. The polymer was recovered by
precipitating the concentrated solution from cold hexane and dried under vacuum and
named as P(αN3εCL)-b-PCL. From SEC characterization, Mn of the polymer is 18.3 k with
Ð = 1.42. 1H NMR (CDCl3, ppm): 4.17 (t, -CHN3COOCH2-), 4.05 (t, -CH2COOCH2-),
3.85 (t, -CHN3COOCH2-), 2.27 (t, -CH2COOCH2-), 1.93-1.25 (broad, -CH2CH2CH2- and
-CHN3CH2CH2-).

1.2.5. Synthesis of P(CL-g-Py)-b-PCL Diblock Copolymers. The azide group containing
diblock copolymer P(αN3εCL)-b-PCL was modified with nicotinic propargyl ester through
a CuAAC coupling process as follows. Polymer P(αN3εCL)-b-PCL (0.18 g, 0.43 mmol N3) and nicotinic propargyl ester (0.11 g, 0.7 mmol) and THF (3.0 mL) were mixed in a 10
mL round bottle flask and purged with N2 for 20 min. In a 10 mL Schlenk flask, CuI (7.6
mg, 0.04 mmol) and DBU (9.0 mg, 0.06 mmol) were dissolved in 1.5 mL THF and 0.5 mL
DMF. The flask was then degassed by three cycles of freeze-pump-thaw and refilled with
N2. The solution with CuI/DBU was stirred for 30 min before transferred into the flask
with the polymer solution to start the Click reaction. The reaction proceeded for 4 hr at 35
°C and a full conversion of the azide functionality was confirmed through FT-IR. DCM
(10 mL) was added to dilute the solution, which was later washed with saturated EDTA
solution for 6 times (8 hr each time) under gentle stirring. The polymer solution was dried
with anhydrous MgSO4, centrifuged and concentrated under vacuum rotary evaporation
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before precipitated out from cold diethyl ether. The product was dried under vacuum and
named as P(CL-g-Py)-b-PCL. The theoretic molecular weight was calculated to be 24.2 k.
From SEC characterization, the molecular weight was 16.8 k with Ð = 1.25. 1H NMR
(CDCl3, ppm): 9.23, 8.78, 8.42, 7.50 (m, aromatic, pyridine), 8.00 (s, triazole, -CH=C-),
5.53 (s, -triazole-CH2-OOC-), 5.33 (s, -triazole-CH-CH2-), 4.23-3.94 (broad, COOCH2CH2-), 2.27 (t, -CH2COOCH2-), 1.93-1.25 (broad, -CH2CH2CH2- and -triazoleCHCH2CH2-).

1.2.6. Preparation of Tf and Polymer CSNPs. Core-shell nanoparticles of Tf and
pyridine-grafted polymers, P4VP and P(CL-g-Py)-b-PCL, were prepared using the
following method. Varied concentrations of Tf aqueous solutions (3.0 mL) were firstly
prepared in 5.0 mL vials, and 100 μL P4VP solution (2.0 mg/mL in THF) was added
dropwise to the Tf solution under vigorous stirring. The solutions were stirred for 2 hr
before evaporating organic solvent overnight. Tf/P4VP and Tf/P(CL-g-Py)-b-PCL CSNPs
with varied mass ratios of protein to polymer (0.3, 1, 2 and 3) were prepared by the same
procedure.

1.2.7. DOX Loading in Tf/P(CL-g-Py)-b-PCL CSNPs. Doxorubicin hydrochloride
(DOXHCl) in DMSO (10 mg/mL) was stirred with 3 equivalent triethylamine (TEA) in
dark for 2 hr at room temperature to neutralize HCl. A mixture solution of hydrophobic
DOX and P(CL-g-Py)-b-PCL was prepared and added to Tf solution dropwise under
stirring. In order to obtain high protein coverage on the particle surface, the weight ratio of
9

protein to polymer was selected as 3:1. Meanwhile, the weight ratio of polymer to drug
was 4:1 as higher drug concentration leaded to precipitation of DOX from the solution. The
volume of organic solvent was kept at 3% (v/v) of the protein aqueous solution while the
final polymer concentration was constant as in the previous step. After self-assembly,
organic solvent and excessive drug were removed by dialysis against DI water. DOX
concentration in the dialyzed particle solution was determined by UV-vis at 480 nm using
the extinction coefficient 11500 M-1cm-1. Both loading efficiency (LE%) and loading
capacity (LC%) based on weight were calculated according to the following equations.

LE% = weight of DOX encapsulated / weight of total DOX × 100%

LC% = weight of DOX encapsulated / weight of polymer × 100%

1.2.8. Cell Culture. MCF10A and MCF7 were obtained from ATCC. Both cells were
grown on standard tissue culture plastics in a 5% CO2 humidified incubator at 37 °C. The
growth medium for MCF10A was DMEM/F12 (1:1, v/v), supplemented with 5% horse
serum, 20 ng/mL human epidermal growth factor (hEGF), 10 μg/mL insulin, 0.5 μg/mL
hydrocortisone, 100 ng/mL cholera toxin, and 1% penicillin/streptomycin antibiotics.
MCF7 cell culture medium was DMEM with 10% fetal bovine serum (FBS), 10 μg/mL
insulin and 1% penicillin/streptomycin antibiotics.

1.2.9. Cell Viability Assay. Biocompatibility of P(CL-g-Py)-b-PCL was tested on both
MCF10A and MCF7, and cell viability was determined by CellTiter-Blue assay. Briefly,
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cells were seeded on a 96-well plate at a density of 1.5 × 104 cell/well and incubated at 37
°C with 5% CO2 for 24 hr. Then, the cell culture medium was replaced with 100 µL of
fresh medium containing various concentrations of test samples. After 24 hr incubation,
test samples were removed, and 10% CellTiter-Blue Reagent was added to each well and
incubated for 4 hr. The fluorescence was recorded on a Spectramax Gemini EM
spectrophotometer with an excitation wavelength of 560 nm and an emission wavelength
of 590 nm.

1.2.10. Cellular Uptake Assessment. Confocal laser scanning microscopy. Cells were
seeded on a 12-well plate with a glass cover slip at the bottom of each well (1 × 105
cells/well) and incubated at 37 °C with 5% CO2 for 24 hr. The medium was replaced
respectively with free DOX, P(CL-g-Py)-b-PCL/DOX, and Tf/P(CL-g-Py)-b-PCL/DOX
solutions (1 µg/mL of DOX) for another 4 hr incubation. Cells were washed 3 times with
1×phosphate-buffered saline (PBS) and fixed by 4% paraformaldehyde (PFA) for 20 min
at room temperature. After washing 3 times with PBS, cells were stained by 4', 6diamidino-2-phenylindole (DAPI) for 10 min and kept in PBS. Confocal microscopy was
used to record images.

In Vitro Flow Cytometry Study. In order to compare the targeting efficiency of Tf/P(CL-gPy)-b-PCL/DOX and P(CL-g-Py)-b-PCL/DOX, flow cytometry was used. MCF10A and
MCF7 cells were seeded on 6-well plates (1 × 106 cells/well) and cultured for 24 hr in
incubator. Cells were respectively treated with fresh medium containing free DOX, P(CL11

g-Py)-b-PCL/DOX and Tf/P(CL-g-Py)-b-PCL/DOX (the DOX concentration was 1
µg/mL). Cells without any treatment were used as control. After 4 hr incubation, different
cells were washed with serum free medium, trypsinized, washed 3 times with PBS, fixed
by 4% PFA and washed with PBS. Cell suspensions in PBS were subjected to fluorescent
measurement.

1.3 RESULTS AND DISCUSSION
1.3.1. Synthesis of P(CL-g-Py)-b-PCL Diblock Copolymers. As previously reported,3031, 33-34

CSNPs can be easily constructed from P4VP and proteins with the aid of non-

covalent interactions. Since the toxicity and non-degradable properties of P4VP limit the
application of CSNPs, the use of biocompatible polymers could endow CSNPs with ideal
properties. In the current research, we synthesized a pyridine grafted diblock copolymer
P(CL-g-Py)-b-PCL as shown in Scheme 1.2. There are three main reasons for using this
block copolymer: a biodegradable polymer backbone based on PCL; the ability to interact
with proteins through pyridine-grafted hydrophilic block; and improved loading capacity
for anticancer drugs using hydrophobic PCL.

Diblock copolymer P(CL-g-Py)-b-PCL was prepared through the combination of
sequential ring-opening polymerization and CuAAC reaction. 1H NMR spectra of
P(αClεCL) and P(αClεCL)-b-PCL proved the success of chain extension, as new peaks
referring to PCL were observed at 4.05 ppm and 2.30 ppm (Figure 1.1A). The repeat unit
number for P(αClεCL) was calculated theoretically to be 42, since the feeding
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monomer/initiator ratio was 42 and full conversion was achieved before adding the second
monomer CL. The length of PCL block was calculated to be 100 repeat unit referring to
the peaks between 4.1-4.3 ppm from P(αClεCL) (Figure 1.1A). The block structure of
P(αClεCL)-b-PCL was further confirmed through
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C NMR characterization in

comparison with a random copolymer P(αClεCL-co-CL). For the carbonyl region, only
two peaks for homotriads C-C-C and ClC-ClC-ClC were observed from P(αClεCL)-bPCL, while additional peaks from heterotriads were found for the random copolymer
P(αClεCL-co-CL) (Figure 1.1B). For the methylene -CH2-O- region, two peaks were
found from the block copolymer referring to the homodiads C-C and ClC-ClC, while two
additional peaks were found due to the ClC-C heterodiads in P(αClεCL-co-CL) (Figure
1.1C).49

After the azide substitution, the proton next to the chloro group completely shifted from
4.27 to 3.85 ppm (Figure 1.1A). P(CL-g-Py)-b-PCL was prepared by the CuAAC reaction
between P(αN3εCL)-b-PCL and nicotinic propargyl ester. From the 1H NMR spectrum of
P(CL-g-Py)-b-PCL (Figure 1.1D), characteristic peaks for the pyridine moieties were
observed at 9.21, 8.78, 8.40, and 7.50 ppm, respectively. Also, the proton on the triazole
group was found at 8.00 ppm. The molecular weight of the P(CL-g-Py) block is about
13.0×103 g/mol as each repeat unit of P(αN3εCL) was modified by nicotinic propargyl ester
after the click reaction. We expect this pyridine grafted block P(CL-g-Py) could help to
stabilize protein via hydrogen bonding interactions. As discussed above, PCL block has
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100 repeat units and a molecular weight of 11.4×103 g/mol. Amphiphilic block copolymers
with similar PCL length have been frequently used for loading hydrophobic drugs in
micellar structures.50-51

Figure 1.1 (A)1H NMR spectra of P(αClεCL), P(αClεCL)-b-PCL, P(αN3εCL)-b-PCL; 13C
NMR spectrum comparison of (B) the carbonyl region and (C) the -OCH2- region between
P(αClεCL)-b-PCL and P(αClεCL-co-CL); (D) 1H NMR spectra of nicotinic propargyl
ester, P(CL-g-Py)-b-PCL.
The azide substitution and CuAAC reaction to P(αClεCL)-b-PCL were also
characterized by FT-IR (Figure 1.2A), which showed a characteristic strong absorption
peak of azide group at 2102 cm-1 after the substitution. After the click reaction, a new peak
at 1593 cm-1 corresponding to the pyridine group was shown together with the complete
disappearance of the azide peak. These polymers were also characterized by SEC as shown
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in (Figure 1.2B), and the molecular weight and polydispersity index were summarized in
Table 1.1.

Figure 1.2 (A) FT-IR spectra of P(αClεCL)-b-PCL, P(αN3εCL)-b-PCL and P(CL-g-Py)b-PCL; (B) SEC traces of P(αClεCL), P(αClεCL)-b-PCL, P(αN3εCL)-b-PCL and P(CL-g-Py)-bPCL.

Table 1.1 Molecular weight of the prepared polymers.
Polymer

Mn (k)

Ð

PClCL

13.3

1.32

PClCL-b-PCL

18.1

1.39

PN3CL-b-PCL

18.3

1.43

P(CL-g-Py)-b-PCL

16.8

1.25

1.3.2. Assembly of Tf and Pyridine-Grafted Polymers. The construction and
characterization of CSNPs have been systematically discussed in our previous studies. 30-34
As depicted in Scheme 1.1, we constructed Tf/P(CL-g-Py)-b-PCL CSNPs and investigated
their particle size distribution, stability and protein folding, while using Tf/P4VP CSNPs
as the control. The co-assembly behavior of Tf/P(CL-g-Py)-b-PCL was examined in
comparison with Tf/P4VP. Varied mass ratios of Tf to polymer (0.3, 1, 2, and 3) were
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attempted in the assembly process. The particle size of Tf/P4VP CSNPs was dependent on
the mass ratio of protein to polymer (Figure 1.3A), consistent with our previous studies.33
The average size decreased from 194 nm to around 127 nm after increasing the mass ratio
of protein to polymer from 0.3 to 1, 2, and 3. (Table 1.2). On the other hand, the particle
size of Tf/P(CL-g-Py)-b-PCL was relatively independent on the mass ratios (Figure 1.3B),
as there was only a small change from 96 nm to 77 nm after increasing the mass ratio
(Table 1.2). This could be explained by the additional stabilization effect from the
hydrophobic PCL block, which dictates the final particle sizes. Representative TEM
images of Tf/P4VP (Figure 1.3C) and Tf/P(CL-g-Py)-b-PCL CSNPs (Figure 1.3D)
showed that the assembled structures were spherical nanoparticles, similar to our previous
reports.30-31, 33-34 Apparent core-shell structures were observed and the thickness of the shell
layer was measured to be in the range of 10 - 15 nm for Tf/P4VP CSNPs and 15 - 30 nm
for Tf/P(CL-g-Py)-b-PCL CSNPs respectively.
Table 1.2 Characterization of Tf/P4VP and Tf/P(CL-g-Py)-b-PCL CSNPs by DLS.
Polymer

P4VP

P(CL-g-Py)-b-PCL

Tf/Polymer (w/w)

0.3

1

2

3

0.3

1

2

3

Size (nm)

193.7

127.9

127.8

124.2

95.8

82.2

77.4

82.0

PDI

0.048

0.099

0.100

0.117

0.164

0.155

0.197

0.145

Zeta potential (mV)

-23.2

-26.2

-25.0

-26.5

-31.5

-36.6

-33.9

-33.1

In a control experiment, polymer solution was added into pure water without Tf. P4VP
precipitates were observed in 2 hr due to its hydrophobic property and the absence of
stabilization effect from Tf. For P(CL-g-Py)-b-PCL, it could form stable colloids in an
16

aqueous solution with no precipitates even after four months. Again, this difference may
be attributed to the amphiphilic property of P(CL-g-Py)-b-PCL, which leads to formation
of micelle-like particles even without Tf as the stabilization reagent.

Figure 1.3 Characterization of Tf/P4VP and Tf/P(CL-g-Py)-b-PCL CSNPs. Size
distribution of Tf/P4VP (A) and Tf/P(CL-g-Py)-b-PCL (B) CSNPs from DLS analysis with
different mass ratios of protein to polymer. TEM images of Tf/P4VP (C) and Tf/P(CL-gPy)-b-PCL (D) based CSNPs; scale bars represent 200 nm. CD spectra of free Tf, Tf/P4VP
(E) and Tf/P(CL-g-Py)-b-PCL (F).
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The interaction between polymer and protein influences the protein conformation and
function. After assembly with different polymers, the Tf structure was analyzed by circular
dichroism spectroscopy.52-53 When the mass ratio of protein to polymer was 0.3, the Tf
folding on both Tf/P4VP (Figure 1.3E) and Tf/P(CL-g-Py)-b-PCL (Figure 1.3F) CSNPs
matched well with the free Tf. With the increase of mass ratios of protein to polymer,
stronger α helix and β sheet signals were detected at around 195 nm and 208 nm - 222 nm
from both types of CSNPs, especially from Tf/P(CL-g-Py)-b-PCL. From the CD spectra
we could conclude that the original conformation of Tf was well maintained after the
assembly process. The retention of protein structure on both types of CSNPs proved the
superior advantage of the co-assembly strategy in assisting protein folding and maintaining
protein activity.

The stability of nanoparticles was also tracked by DLS. For Tf/P4VP CSNPs from the
mass ratio of protein to polymer at 0.3, precipitates were observed after one week storage
at 4 °C. The particle average size and polydispersity distribution index (PDI) increased, as
indicated by the DLS measurement (Figure 1.4A and 1.4B). The Tf/P4VP CSNPs with
higher masses ratios (1, 2, 3) were more stable and did not show significant change of the
average size and PDI upon storing for one month. In comparison, Tf/P(CL-g-Py)-b-PCL
CSNPs showed no significant change in particle average size and PDI even after storage at
4 °C for up to four months (Figure 1.4C and 1.4D). These results indicated an enhanced
stability for the diblock copolymer based CSNPs than those from P4VP. The improved
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stability of Tf/P(CL-g-Py)-b-PCL CSNPs from Tf/P4VP CSNPs was attributed to the
amphiphilicity of P(CL-g-Py)-b-PCL. While the poly(caprolactone-g-pyridine) block can
effectively interact with corona proteins, the polycaprolactone block can segregate and
form a stable core structure due to its hydrophobic nature.

Figure 1.4 Average particle size and PDI of Tf/P4VP (A and B) and Tf/P(CL-g-Py)-b-PCL
(C and D) CSNPs in stability tracking from DLS.
The stability of CSNPs in ionic condition and in serum is vital to the in vivo drug
delivery application. Therefore, the stability of Tf/P(CL-g-Py)-b-PCL CSNPs in PBS as
well as in the presence of serum proteins were tested. As shown in Figure 1.5, CSNPs were
stable for 72 hr under both conditions at 37 °C, as tracked by DLS. These results also
consistent with our previous studies. 35, 54
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Figure 1.5 Stability study of Tf/P(CL-g-Py)-b-PCL CSNPs in PBS and 10% FBS in 72 hr.
1.3.3. DOX Loaded Nanoparticle Preparation and Characterization. Tf/P(CL-g-Py)b-PCL CSNPs were later used as a potential drug delivery vehicle as the PCL block can
help to encapsulate hydrophobic molecules through the hydrophobic-hydrophobic
interaction (Scheme 1.1).55-57 DOX was selected as a prototypical anticancer drug. It was
dissolved together with P(CL-g-Py)-b-PCL and added into Tf aqueous solution. The mass
ratio of Tf to polymer at 3 was chosen to ensure a maximum protein coverage on the
particle surface. The mass ratio of polymer to drug was 4:1 since higher drug concentration
lead to apparent precipitation of DOX from the solution. As a control, drug loaded particles
without Tf were prepared. The Tf/P(CL-g-Py)-b-PCL/DOX and P(CL-g-Py)-b-PCL/DOX
particles were characterized by DLS (Figure 1.6A) and TEM (Figure 1.6B). The
encapsulation of DOX did not show a significant influence on the size distribution and
morphology of nanoparticles. The drug loading efficiency was in the range of 50% - 60%
and loading capacity was about 10% - 15% (Table 1.3).
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Figure 1.6 (A) DLS analysis of DOX loaded P(CL-g-Py)-b-PCL nanoparticles (black line)
and Tf/P(CL-g-Py)-b-PCL (red line) CSNPs. (B) TEM image of DOX loaded Tf/P(CL-gPy)-b-PCL CSNPs. Scale bar represents 200 nm.
Table 1.3 Characterization of DOX loaded particles.
CSNPs

LE%

LC%

Size (nm)

PDI

ς (mV)

Polymer/DOX

58%

11%

101

0.127

-37.6

Tf/Polymer/DOX

53%

10%

120

0.193

-40.3

1.3.4. Cell Studies. Polymer cytotoxicity, and cellular uptake of P(CL-g-Py)-b-PCL/DOX
and Tf/P(CL-g-Py)-b-PCL/DOX were investigated on MCF10A and MCF7 cells. First,
P(CL-g-Py)-b-PCL cytotoxicity was tested by CellTiter Blue assay. MCF10A and MCF7
treated with P(CL-g-Py)-b-PCL nanoparticles (without Tf coating) showed above 90% cell
viability, indicating excellent biocompatibility of this new block copolymer (Figure 1.7).
To evaluate the active targeting ability of Tf/P(CL-g-Py)-b-PCL CSNPs, TfR negative cells
MCF 10A and TfR positive cells MCF7 were employed. With the DOX concentration at 1
µg/mL, free DOX, P(CL-g-Py)-b-PCL/DOX, and Tf/P(CL-g-Py)-b-PCL/DOX were
incubated with these two types of cells for 4 hr respectively. Cells were fixed and stained
with DAPI to show the nucleus in blue. DOX has intrinsic red fluorescence and can
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intercalate into DNA strands in the nucleus. Confocal images clearly showed the uptake of
free DOX, P(CL-g-Py)-b-PCL/DOX, and Tf/P(CL-g-Py)-b-PCL/DOX in MCF10A and
MCF7 cells (Figure 1.8).

Figure 1.7 Cytotoxicity study of P(CL-g-Py)-b-PCL on MCF10A and MCF7 cells.

Figure 1.8 Confocal microscopic images of MCF10A (left) and MCF7 (right) cells after 4
hr incubation with free DOX (A), P(CL-g-Py)-b-PCL/DOX (B) and Tf/P(CL-g-Py)-bPCL/DOX (C). Scale bars represent 50 µm. DOX concentration was 1 µg/mL.
Further quantification of nanoparticles uptake was evaluated by fluorescent activated
cell sorting. Cells incubated with free DOX, P(CL-g-Py)-b-PCL/DOX, and Tf/P(CL-g-Py)22

b-PCL/DOX for 4 hr were trypsinized, washed, fixed, suspended in PBS, and subjected to
flow cytometry. Cells without any treatment were used as control. As depicted in Figure
1.9A, in MCF10A cells, which have normal expression level of transferrin receptor, the
uptake of both nanoparticles gave no apparent difference. However, in TfR overexpressed
MCF7 cells, higher uptake of Tf/P(CL-g-Py)-b-PCL/DOX than P(CL-g-Py)-b-PCL/DOX
was observed (Figure 1.9B). The difference in uptake efficiency indicated the enhanced
targeting ability of Tf/P(CL-g-Py)-b-PCL CSNPs and its potential application as a drug
delivery vehicle.

Figure 1.9 Flow cytometry analysis of MCF10A (A) and MCF7 cells (B) cellular uptake
of free DOX (blue curve), P(CL-g-Py)-b-PCL/DOX (green curve), and Tf/P(CL-g-Py)-bPCL/DOX (red curve), cells without any treatment as control (black curve).
1.4 CONCLUSIONS

In conclusion, we successfully synthesized a novel pyridine grafted diblock copolymer
P(CL-g-Py)-b-PCL through ROP and CuAAC reactions. The CSNPs fabricated from this
23

dibolck copolymer could not only maintain Tf conformation, but also exhibit narrower
range of particle sizes and higher stability than those constructed with homopolymer P4VP.
The anticancer drug DOX was successfully loaded into the diblock copolymer based
CSNPs. The Tf/P(CL-g-Py)-b-PCL/DOX particles can be uptaken by both MCF10A and
MCF7 cells, but with higher targeting efficiency on TfR overexpressed MCF7 cells than
TfR normal expressed MCF10A cells. Therefore, the drug loaded Tf/P(CL-g-Py)-b-PCL
CSNPs have the ability of actively targeting TfR overexpression cancer cells and can be
potentially employed as a drug delivery vehicle.
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CHAPTER 2 ARTIFICIAL CELLULOSOME COMPLEX FROM THE SELFASSEMBLY OF PYRIDINE GRAFTED POLYMERS AND CELLULASES
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2.1 INTRODUCTION
Due to the global warming and energy crises, the exploration and innovation of renewable
energy source for the substitution of fossil fuels are becoming extremely essential.
Currently, there are increasing interests to produce sustainable and environment friendly
chemicals and fuels from plant biomass. 1-3 Plant biomass contains polysaccharides, mainly
cellulose and hemicellulose, and the complex cross-linked phenolic polymer lignin, which
is major source of carbon and energy. In nature, microorganisms, such as bacteria and
fungi, are able to degrade the plant biomass through cellulosome, a complex of
synergistically acting enzymes. 4-5 Cellulosome are mainly composed of cellulose binding
domain (CBD), and several repeating cohesion domains, which are docked individually
with a different cellulases tagged with the corresponding dockerin domains. 6 The highly
ordered architecture of cellulosome provides the assembled multiple enzymes close
proximity and allows high rates of cellulose sequential hydrolysis and degradation via
synergistic effects. However, the application of native cellulosome for large-scale biomass
hydrolysis is still a major bottleneck in biofuel production since the full-length cellulosome
cannot be efficiently recovered. 7-8
To overcome the technical and economic barriers in biofuel conversion, a variety of
artificial cellulosome have been developed for the utilization of biomass through biological
enzyme processing. 9-19 A general strategy is to immobilize multiple enzymes via different
interactions to increase the local enzyme concentration and synergistic effects in the
hydrolysis of recalcitrant cellulose substrate.

9-10, 20-21

designed by Edward A. Bayer and coworkers.

The first artificial cellulosome was

20, 22

They designed several chimeric

scaffoldins and hybrid enzymes. The chimeric scaffoldins comprised an optional CBD and
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two cohesion domains from different species, one from Clostridium thermocellum and
another from Clostridium cellulolyticum. Recombination enzyme constructs contained a
catalytic module together in the same polypeptide chain with a dockerin domain from either
species. The cellulosome chimeras were assembled in vitro, simply by combining
equimolar amounts of three desired components, i.e. the chimeric scaffoldin and two
enzymes. The resultant complex exhibited enhanced synergistic action on crystalline
celluloses as compared with the mixture of free cellulases.

20, 22

Chen and coworkers

utilized the yeast cells consisting of cohesion domains from different species on the cell
surface to display three cellulases including endoglucanase, exoglucanase and βglucosidase fused with different dockerins.

9, 23-24

The specific interaction between

cohesion and dockerin ensured the successful fabrication of minicellulosomes. The
displayed minicellulosome retained the synergistic effect for cellulose hydrolysis. They
also successfully demonstrated the concept of using adaptive strategy for ex vivo assembly
of a functional tetravalent designer cellulosome on the yeast cell surface. In addition to
yeast cells, Chen group explored DNA double helix and quantum dots as scaffolds for the
artificial cellulosome construction. 10, 21, 25 Different from using cohesion-dockerin affinity
binding, the proteins can be site-specifically localized onto a double-stranded DNA
scaffold using zinc-finger proteins or can be orientally placed on the surface of quantum
dots via polyhistidine-mediated enzyme-QD conjugation. Kim and his colleagues reported
the immobilization of endoglucanases and CBDs onto gold nanoparticles via the highaffinity biotin and streptavidin interaction for enhanced cellulose hydrolysis.

17

Low-cost

nanomaterials, such as magnetic nanoparticles and recyclable thermoresponsive polymers,
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were developed in other research groups. They were conjugated with the cellulases by
covalent bond and realized the enhanced enzyme activity through proximity effect. 11, 26
In our previous research, we reported the fabrication of polymer-protein core-shell
nanoparticles (CSNPs) from the coassembly of pyridine-grafted polymers with various
proteins and protein nanoparticles. It has been demonstrated that CSNPs have the ability
to retain the original protein conformation and promote protein folding on the particle
surface, meanwhile, they have shown potential applications in biomedical field. 27-29 In this
chapter, we are aiming to explore the application of CSNPs in enzyme immobilization. We
hypothesize that the cellulases could be immobilized on CSNPs surface after co-assembly
with pyridine functionalized polymers. Local enzyme concentration can be thus increased
as compared to free enzyme in the solution. Potentially, the assembled cellulases would
show enhanced activity than free ones in hydrolysis of cellulose due to enzyme proximity
effect. In the current work, cellulases from different species were expressed and purified.
CSNPs from the co-assembly of these cellulases and different pyridine-grafted polymers
were studied over their activity in cellulose hydrolysis with free unassembled cellulases as
the control.
2.2 MATERIALS AND METHODS
2.2.1 Materials. EasyPfu DNA polymerase, DpnI, T4 DNA polymerase, Rosetta2 (DE3)
cells,

DH5α

competent

cells,

pET-28

vector,

kanamycin,

isopropyl-D-

thiogalactopyranoside (IPTG), bacterial protein extraction reagent (B-PER), poly(4vinylpyridine) (P4VP), Sigmacell, Na 2CO3, KCl, K3[Fe(CN)6], alum(ferric-ammonium
sufate), sodium dodecyl sulfate (SDS), sulfuric acid. All enzymes were purchased from
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New England Biolabs and used as received. All chemicals were purchased from SigmaAldrich and used as received.
2.2.2 Plasmids information. Plasmids pET24a-CelAt, pET24a-CelGc, pET24a-CelEc and
pET9b-Bglf were obtained from Dr. Wilfred Chen. Plasmids pET19b-CelF (Cel9B),
pET19b-Cel9K, pET19b-Cel9R, and pET19b-Cel48S were generously given by Dr.
Jonathan D. Trent. The cellulases are from species Clostridium thermocellum (CT) or
Clostridium celluolyticum (CC). The detailed plasmids information is listed in Table 2.1
below.
2.2.3 Plasmids mutation. The plasmids received from Dr. Trent group have no 6×His tag.
To purify large quantity of cellulases by using Histrap TM column, 6×His-tag was inserted
in the C-terminus of the proteins CelF, Cel9K, Cel9R, and Cel48S. The sequence and
ligation-independent cloning (SLIC) method was used for His-tag insertion. 30 The primers
needed for polymerase chain reaction (PCR) were designed and listed below in Table 2.2.
The protein genes were amplified by using EasyPfu DNA polymerase. After PCR
amplification, 20 U of DpnI was added to the reaction and incubated at 37 ℃ for 1 hr to
digest the template. The PCR products were purified by using the PCR purification column.
Next, 1 µg of vector and 1 µg of inserts were separately treated with 0.5 U of T4 DNA
polymerase in 20 µL reactions at 22 ℃ for 40 min. The reactions were stopped by adding
1/10 volume of 10 mM dCTP. About 150 ng of digested vector was mixed with appropriate
amount of inserts (1:1 molar ratio to vector) in a 10 µL annealing reaction with 1× ligation
buffer and incubated at 37 ℃ for 30 min. Then, 5 µL of the annealing mix was transformed
into 100 µL of DH5α competent cells and plated onto kanamycin agar plates. The success
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of 6×His-tag insertion in the C-terminal of CelF, Cel9R and Cel48S was confirmed by
sequencing.
2.2.4 Optimization of cellulases expression condition. From the gene sequences analysis,
the cellulases contain around 10% of rare codons. The Rosetta2 (DE3) host strain is BL21
derivative designed to enhance the expression of eukaryotic proteins that contain codons
rarely used in E. coli. Therefore, in this study, we chose Rosetta2 (DE3) cells and
transferred all the cellulase plasmids into them for protein expression. Cells were
precultured overnight at 37 ℃ in LB medium supplemented with 50 µg/mL of kanamycin.
The pre-culture was sub-inoculated when the OD600 reached between 0.6-0.8. Cells were
cooled down to 16 ℃ and induced by different concentrations of IPTG. After 16 hr culture,
cells were harvested by centrifugation (8,000 × g, 10 min) at 4 ℃, then washed by pH 8.0,
50 mM, Tris-HCl buffer. The cells were lysed by bacterial protein extraction reagent (BPER) and the protein expressions were analyzed according to the manufacture’s protocol.
The optimized induction conditions were used for large scale cell culture.
2.2.5 Cellulases purification. All the cellulases were purified by Histrap

TM

column. The

harvested cells were resuspended in binding buffer (pH 8.0, 50 mM Tris-HCl, 100 mM
NaCl, 5 mM imidazole) and lysed with a sonicator. Cell lysate was centrifuged at 8,000 ×
g, 30 min, 4 ℃, and the supernatant was filter by 0.22 µm membrane and loaded on Histrap
TM

column. Cellulases were eluted by elution buffer (pH 8.0, 50 mM Tris-HCl, 100 mM

NaCl, 150 mM imidazole) then dialyzed against pH 8.0, 50 mM Tris-HCl buffer, aliquoted,
and stored at -80℃.
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Table 2.1. Summary of cellulase plasmids information
Plasmid

Source

Protein Description

Restriction Sites

M.W.

Tag

pET24a-CelAt

CT

CelAt, endoglucanase, with native dockerin,

NdeI/XhoI

~50 kD

6×His

NdeI/XhoI

~50 kD

6×His

NdeI/XhoI

93.8 kD

6×His

NdeI/BglII

51.5 kD

6×His

NcoI/XhoI

79.5 kD

No

no CBD.
pET24a-CelGc

CC

CelGc, endoglucanase, with dockerin from
C. thermocellum, no CBD.

pET24a-CelEc

CC

CelEc, exoglucanase, with native dockerin,
with CBD.

pET9b-Bglf

CT

Bglf, β-glucosidase, with dockerin from R.
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flavefaciens.
pET28b-CelF

CT

(Cel9B)

CelF (Cel9B), endoglucanase, with native
CBD.

pET28b-Cel9K

CT

Cel9K, exoglucanase, with native CBD.

NcoI/XhoI

79.5 kD

No

pET28b-Cel9R

CT

Cel9R, endoglucanase, with native CBD.

NcoI/XhoI

97.8 kD

No

pET28b-Cel48S

CT

Cel48S, exoglucanase, no CBD.

NcoI/XhoI

80.8 kD

No

Table 2.2 Primers information for PCR.
Cel9KF

5’-TGTTTAACTTTAAGAAGGAGATATACCATGGGCCTGGAAGACAAGTCTC-3’

Cel9KR

5’-GATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTTTATGTGGCAATACATCTA-3’

Cel48SF

5’-TGTTTAACTTTAAGAAGGAGATATACCATGGGTCCTACAAAGGCACCTACA-3’

Cel48SR

5’-GATCTCAGTGGTGGTGGTGGTGGTGCTCGAGGTTCTTGTACGGCAATGTA-3’
5’-TGTTTAACTTTAAGAAGGAGATATACCATGGGTGCGGATTTCAACTATG-3’

CelFR

5’-GATCTCAGTGGTGGTGGTGGTGGTGCTCGAGCTGTTCAGCCGGGAATTT-3’

Cel9RF

5’-TGTTTAACTTTAAGAAGGAGATATACCATGGGTGCAGACTATAACTATGGA-3’

Cel9RR

5’-GATCTCAGTGGTGGTGGTGGTGGTGCTCGAGGCTGTTTCCGGGTATGGT-3’
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CelFF

SLIC-CTCBD-F

5’-TGTTTAACTTTAAGAAGGAGATATACCATGGGTGCAAATACACCGGTATCAGGCAAT-3’

SLIC-CTCBD-R

5’-GATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTACTACACTGCCACCGGGTTCTTTA-3’

2.2.6 Preparation of polymer-cellulase core-shell nanoparticles. Poly(4-vinylpyridine)
(P4VP) and pyridine grafted poly(hydroxyethyl methacrylate) (PHEMA-Py) were used to
study their co-assembly properties with cellulases. In a typical assembly process, different
concentrations of cellulases aqueous solutions (3 mL) were prepared in 5 mL vials, and
100 µL of polymer dissolved in organic solvent (2 mg/mL) was added dropwise to the
protein solution under vigorous stirring. Samples with different mass ratios of protein to
polymer were prepared by the same procedure and the volume of organic solvent was less
than 5%. The assembled CSNPs were characterized by dynamic light scattering (DLS) and
transmission electron microscopy (TEM).
2.2.7 Cellulase activity assay. The activity of cellulases were measured by ferricyanide
assay.
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The free cellulases or the assembled polymer-cellulase core-shell nanoparticles

were mixed with Sigmacell (final 0.2%) and incubate at 37 ℃. Aliquots were taken out
and centrifuged at 5,000 × g for 5 min at different time points for the activity assay. In a
typical measurement, 150 µL of supernatant was first mixed with 150 µL of solution Ⅱ (50
mM Na2CO3, 10 mM KCl) and 150 µL of solution Ⅰ (1.5mM K3[Fe(CN)6]). The mixture
was heated at 95 ℃ for exactly 15 min and cooled down to room temperature. Then, 750
µL of solution Ⅲ [0.15% alum(ferric-ammonium sufate), 0.1% SDS-0.05N sulfuric acid]
was added and incubated at room temperature for 15 min before measuring absorbance @
690 nm.
2.3 RESULTS AND DISCUSSION
2.3.1 Plasmid mutation. The Cellulases CelF, Cel9K, Cel9R, and Cel48S have no 6×Histag. Therefore, we used SLIC method and inserted 6×His-tag on the C-terminal of each
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cellulase. 30 The insertion results were confirmed by gene sequencing.
2.3.2 Optimization of cellulases expression condition. There are about 10% of rare
codons in the cellulases from the gene sequence analysis. Thus, the plasmids were
transformed into Rosetta2 (DE3) strain, which was able to enhance the expression of
proteins containing rare codons. The expression conditions of cellulase were optimized by

Figure 2.1 Cellulases expression level analysis. L, means the cell lysate, P means pellet, S
means supernatant, and M means protein marker (from top to bottom: 180, 130, 95, 72, 55,
and 43 kD).
inducing cells at different concentrations of IPTG. The protein expression levels were
analyzed (Figure 2.1). From the SDS-PAGE, the cellulases CelAt, CelGc, CelEc and CelF
are soluble and their molecular weights match the theoretical values. The Bglf and Cel48S
are insoluble and form inclusion bodies. The cells induced at 300 µM IPTG showed higher
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expression level for CelA, CelG, CelE and Bglf, meanwhile, induced at 500 µM IPTG had
higher expression of CelF and Cel48S.
2.3.3 Protein purification. The cellulases in soluble form, CelAt, CelGc and CelF were
firstly expressed and purified in large scale for constructing polymer-protein CSNPs. From
SDS-PAGE and ImageJ analysis (Figure 2.2), the major bands were very clear and the
purity of these three proteins was around 90%.
2.3.4 Polymer-protein core-shell nanoparticle preparation and characterization. We
firstly tried to prepare polymer-protein CSNPs in pure water. Following a typical protocol,
50 µL of 2 mg/mL of cellulase was added to 1.6 mL pure water, then 50 µL of 2 mg/mL
polymer dissolved in organic solvent was added dropwise to protein solution under
vigorous stirring. After 2 hr stirring, the organic solvent was removed either by evaporation
or by dialysis. P4VP dissolved in ethanol (EtOH) and PHEMA-Py dissolved in
dimethylformamide (DMF) were tested in the assembly process. CelAt, CelGc and CelF
were found to be able to form CSNPs with the chosen polymers.

Figure 2.2 Purification of cellulases CelAt, CelF and CelGc.
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As reported, the optimized pH working condition for cellulases is pH 5.0 ~ 6.0. To meet
the optimal working environment for cellulases, we tried to assembly cellulases and
polymers in pH 6.0, 10 mM Tris-Malate buffer. Following the similar assembly process,
the concentration of cellulase aqueous solution and protein-to-polymer ratio were tuned
during the process. Unfortunately, obvious aggregates were formed after 2 hr stirring no
matter which polymer or protein was used. This might be due to the decreased protein
solubility since the pH value is close to the protein pI and the protein is easy to precipitate
out under stirring.
Based on the results above, the assembly condition was modified by increasing the pH

Figure 2.3 DLS analysis of CelAt, CelGc and CelF assembly with P4VP (A) and PHEMAPy respectively (B). Representative TEM images of assembled CSNPs, CelF/P4VP (C) and
CelF/PHEMA-Py (D). Scale bars 200 nm.
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value to 7.5 by using 20 mM Tris-HCl buffer. From the DLS analysis (Figure 2.3 A and
B), we found that all the three purified cellulases, CelAt, CelGc and CelF, were able to
assemble with P4VP and PHEMA-Py to form CSNPs. The average size of CelAt/P4VP
and CelF/P4VP is about 115 nm. The average size of CelAt/PHEMA-Py and
CelF/PHEMA-Py is about 165 nm. The CelGc/P4VP and CelGc/PHEMA-Py CSPs have
similar average size around 209 nm. TEM images confirmed the assembled spherical
nanoparticles and their polymer core and protein shell. The representative TEM images of
CSNPs CelF/P4VP and CelF/PHEMA-Py are showing below (Figure 2.3 C and D).
2.3.5 Cellulase activity study at different pH conditions. The enzyme activity of
cellulases was evaluated by measuring the production of reducing sugars following the
Park-Johnson method, ferricyanide assay. 31
Using CelF as a model cellulase, we tested its activity at pH 6.0 and pH 7.5. Three
different concentrations, 0.5 µM, 1 µM and 2 µM of CelF, were mixed with Sigmacell
(final concentration 0.2%) in pH 6.0 and pH 7.5 buffer, respectively. The mixture was
incubated at 37 ℃ and shaken on a wheel shaker. From Figure 2.4 A, CelF showed some
catalytic activity at both pH 6.0 and pH 7.5 for all the three concentrations after 4 hr.
However, after 24 hr, the amount of reducing sugar didn’t show any increase (Figure 2.4
B) and obvious protein aggregates showed up at pH 6.0 which indicated that CelF lost
activity. At pH 7.5, a little bit higher amount of reducing sugar was produced after 24 hr,
but didn’t show significant difference as compared with 4 hr. Therefore, the 4 hr time point
and pH 7.5 condition were chosen to study the activity difference of free enzymes and
assembled ones in the following study when measuring the reducing sugar production.
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Figure 2.4 Catalytic activity of CelF (three different concentration, 0.5 µM, 1.0 µM, 2.0
µM) at pH 6.0 and pH 7.5. Reducing sugar amount tested after 4 hr (A) and 24 hr (B).
2.3.6 Solvent effect. As mentioned earlier, the polymer was dissolved in organic solvent
to assist the self-assembly process. Since the solvent was not removed, it is necessary to
check the influence of solvent on the testing results from ferricyanide assay.
Using Sigmacell as the control substrate and CelF as the model enzyme, the influence
of ethanol (EtOH), dimethyl sulfoxide (DMSO), tetrahydrofuran (THF) and DMF on the
test was examined. About 950 µL of 200 µg/mL CelF in pH 7.5, 20 mM Tris-HCl was
mixed with 50 µL solvent or Sigmacell, respectively, then, the mixtures were incubated at
37 ℃ for 4 hr. The ferricyanide assay results showed that DMF gave much higher Prussian
blue production (Figure 2.5). This could be explained by the structure of DMF, which has
aldehyde functional group and can be detected as “reducing sugar” in the enzymatic assay.
Based on the solvent effect, we chose EtOH, THF and DMSO, to dissolve the polymers for
assembly.
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Figure 2.5 Ferricyanide assay measurement of CelF with DMF, EtOH, THF and DMSO.
Substrate Sigmacell was used as control to study the effect of solvent on the test.
2.3.7 Activity comparison of free cellulases and assembled cellulases. Cellulases were
assembled with different pyridine-grafted polymers and their activity was compared with
free cellulases. Cellulase CelF, containing native CBD domain, was firstly tried to
assemble with P4VP and PHEMA-Py dissolved in DMSO. The mass ratio of CelF to
polymer was 1 (Figue 2.6A). Since the organic solvent was not removed, the free CelF
with same volume of DMSO was used as control. From the ferricyanide assay, the CelF
assembled with P4VP and PHEMA-Py has around 20% elevated activity than the free
CelF. Since CelGc and CelAt don’t have native CBD, CBD was also added to their
assembly process with polymers. After assembly with P4VP and PHEMA-Py, respectively,
CelGc and CBD bi-protein showed slightly activity decrease comparing to free CelGc
(Figure 2.6B). Similar phenomenon was observed on CelA and CBD bi-protein assembly
(Figure 2.6 C) system. Beside single cellulase assembly with polymers, we tried bi- and
tri- cellulases assembly with P4VP and PHEMA-Py (Figure 2.6 D and E). The protein to
polymer ratios were also adjusted from 1 to 5 (Figure 2.6 F). Unfortunately, from the
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ferricyanide assay, we didn’t see obvious cellulase activity increase comparing with same
amount of free enzyme.

Figure 2.6 Enzyme activity comparison of (A) free CelF and CelF assembled with P4VP
PHEMA-Py; (B) free CelGc and CelGc assembled with P4VP or PHEMA-Py; (C) free
CelAt and CelAt assembled with P4VP or PHEMA-Py; (D) comparison of unassembled
CelF&CelGc mixture and assembled bi-enzyme; (E) comparison of CelF, CelGc and CelAt
triple enzyme mixture and assembled triple enzyme; (F) comparison of free CelGc and
assembled CelGc with mass ratio of protein to polymer at 1 or 5.
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The observed results from the assembled cellulases were contrary to our hypothesis. No
obvious activity enhancements were achieved after the assembly process. Since the
assembly process was primarily entropically driven and the CSNPs are stabilized by
hydrogen bonding between a variety of protein side chains and pyridine-grafted polymers,
the cellulases are randomly positioned on the particle surface with no preferential
orientation. As a result, the enzyme activity centers might have been buried and hard to
interact with the insoluble cellulose substrate. Previously reported scaffolds, such as yeast,
quantum dots, silica nanoparticles and DNA double helix, anchor the enzyme through sitespecific interactions including cohesion-dockerin specific affinity and His-tag. In these
situations, the immobilized cellulases have more freedom to bind and digest the substrate,
producing more reducing sugars via enzyme proximity effect and synergy effect.
2.4 CONCLUSIONS
In this chapter, we firstly created the cellulase library. We have added 6×His-tag to the
cellulases CelF, Cel9R and Cel48S. The expression condition of cellulases CelAt, CelGc,
CelEc, Bglf, CelF and Cel48S have been optimized. The CelAt, CelGc and CelF were
purified and their purity was around 90%. The DLS and TEM results have demonstrated
that they were able to assembly with polymers P4VP and PHEMA-Py. The enzyme
activities were compared between free enzymes and assembled enzymes. Either the single
CelF, CelGc, CelAt or double-enzyme, or triple-enzyme assembly system, show obvious
elevated enzyme activity as compared to the same amount of free enzyme. We think that
our CSNPs system is not able to control the orientation of proteins displayed on the particle
surface and this causes the catalytic center of cellulases to be buried or hard to interact with
the insoluble cellulose substrate.
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CHAPTER 3 ARTIFICIAL CELLULOSOME COMPLEX FROM THE SELFASSEMBLY OF NTANI FUNCTIONALIZED POLYMERIC MICELLES AND
CELLULASES
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3.1 INTRODUCTION
Development of polymeric nanoparticles from the self-assembly of amphiphilic block
copolymers for a variety of applications is an emerging research direction.

1-3

A great

diversity of functionalities can be obtained from such nanoparticles through polymer
structural design and post-assembly modifications. Proteins, mostly water soluble with size
of a few nanometers, often have special functionalities that are not available from synthetic
polymers. Thus, the assembly of polymer and protein to form hybridized biomaterials can
combine the merits from both. For example, as discussed in Chapter 1, transferrin (Tf), a
water soluble protein of ~3 nm, can provide targeting effect to drug-loaded polymeric
nanoparticles toward cancer cells. 4
In Chapter 2, we attempted to construct core-shell nanoparticles (CSNPs) from the selfassembly of pyridine grafted polymers and cellulases. The cellulases were positioned on
the surface of CSNPs. It was anticipated to exhibit enhanced catalytic activity in
hydrolyzing cellulose due to close proximity as compared to the free cellulases. However,
it turned out that these CSNPs with cellulases positioned on the surface didn’t show any
improvement over free cellulases. We postulated that this was because the assembly
process was not site-selective and the anchored proteins were not oriented correctly to
make the active centers of cellulases accessible to substrates. The aim of this chapter is to
develop a polymeric nanoparticle system, which can be used to anchor the cellulases with
control of the enzyme orientation, thus providing enzyme arranged with close proximity
on the particle surface.
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The method we are employing is to take advantage of the high affinity between NTANi
and His-tag. Polymer nanoparticles with NTANi moieties on the surface and cellulases
with 6×His-tag would be the ideal precursors to achieve our goal. In this chapter, we firstly
designed and prepared an amphiphilic di-block copolymer with poly(styrene) as the
hydrophobic block and NTA modified poly(styrene-alt-maleic anhydride) as the
hydrophilic block. After self-assembly in aqueous solution, Ni2+ ions were added and NTA
was converted to NTANi complex. Using fluorescent proteins as models, we confirmed
that the 6×His-tagged mcherry and eGFP can be captured by NTANi complex on the
surface of the particles with close proximity and the FRET effect between them was
detected. On the other hand, we introduced the cellulases onto the nanoparticles. The
assembled cellulases showed higher catalytic activity than the free ones due to both the
proximity effect and synergy effect.
3.2 MATERIALS AND METHODS
3.2.1

Materials.

All

chemicals,

i.e.

styrene,

(S)-N-(5-Amino-1-

carboxypentyl)iminodiacetic acid (amino-NTA), dinitrosalicylic acid sodium hydroxide,
phenol, sodium sulfite, potassium sodium tartrate, were purchased from Sigma-Aldrich.
Styrene (99%, ACS grade) was passed through a short column of basic Al 2O3 before use.
Maleic anhydride (MA), S’-dodecyl S’-2-(2,2-dimethylacetic acid) trithiocarbonate, 2,2′Azo-bis(isobutylnitrile) (AIBN) was recrystallized from methanol.
3.2.2 Characterization. 1H NMR spectra were obtained on a Varian Mercury 300
spectrometer with tetramethylsilane (TMS) as an internal reference. Fourier transform
infrared spectrometry (FT-IR) spectra were recorded on PerkinElmer spectrum 100 FT-IR
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spectrometer. Molecular weights and polydispersity index (Đ) were analyzed using a gel
permeation chromatography (GPC) equipped with a 2414 RI detector, a 1525 Binary Pump
and three Styragel columns. The columns consisted of HR 1, HR 3 and HR 5E in the
effective molecular weight ranges of 100−5K, 500−30K, and 2K−4M respectively. THF
was used as eluent at 35 °C. The flow rate is 1.0 mL/min. The system was calibrated with
polystyrene standards. GPC samples were prepared by dissolving the sample in THF with
a concentration of 5.0 mg/mL and passing through microfilters with average pore size of
0.2 μm. The glass transition temperature (T g) was tested through differential scanning
calorimetry (DSC) conducted on a DSC 2000 instrument (TA Instruments). Samples were
first heated from −70 to +200 °C at a rate of 10 °C/min. After cooling down to −70 °C at
the same rate, the data were collected from the second heating scan. A 10 mg amount of
each sample was used for the DSC test with nitrogen gas at a flow rate of 50 mL/min. The
hydrodynamic diameter, size distributions and zeta potential were measured with dynamic
light scattering (DLS, Zetasizer Nano ZS, Malvern Instruments). UV-vis measurement was
performed on NanoDropTM 2000c spectrophotometer with 10 mm path length.
Fluorescence spectra were measured on Varian Cary Eclipse spectrometers. Fast protein
liquid chromatography (FPLC) analysis was performed on AKTA explorer (GE Biotech)
using Superose 6 10/300 GL column with the flow rate of 0.5 mL/min. Transmission
electron microscopy (TEM) samples were prepared by depositing 20 μL aliquots of
samples onto 300-mesh carbon-coated copper grids for 5 min and wicked away excess
aqueous solution with filter paper.10 µL of 2% phosphotungstic acid (PTA) was dropped
on the samples for negative staining for 1 min and the excess PTA was also wicked. The
samples were observed with a Hitachi H-8000 transmission electron microscope.
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3.2.3 Synthesis of poly(styrene)-b-poly(styrene-alt-maleic anhydride) (PS-b-PSMA).
PS-b-PSMA diblock copolymers were prepared in a one-step reversible additionfragmentation chain-transfer (RAFT) polymerization strategy. S’-dodecyl S’-2-(2,2dimethylacetic acid) trithiocarbonate was used as the chain transfer agent (CTA) and AIBN
was used as the radical initiator. Ratio of styrene/maleic anhydride/CTA/AIBN is
200:20:1:0.4. Styrene (30 mmol, 3.12 g), maleic anhydride (3.0 mmol, 0.3 g), CTA (0.15
mmol, 33 mg) and AIBN (0.06 mmol, 10.0 mg) were charged into a 25 ml round bottom
flask with 4.0 ml 1,4-dioxane. The sealed flask was put into an ice-water bath and purged
with nitrogen for 15 mins before putting into a 60 oC oil bath to start the polymerization.
1

H NMR was used to track the conversion of the reaction with 1,4-dioxane as the reference.

The reaction was stopped by quenching in ice-water bath with 70% styrene conversion.
Polymer was recovered by precipitation from diethyl ether.
3.2.4 Reaction of PS-b-PSMA with (S)-N-(5-Amino-1-carboxypentyl)iminodiacetic
acid (amino-NTA). PS-b-PSMA prepared above was modified with amino-NTA using dry
DMF as the solvent and TEA as the catalyst. PS-b-PSMA (165 mg, 0.2 mmol anhydride
group) and amino-NTA (20 mg, 0.076 mmol) were dissolved in 1.5 ml dry DMF with 30
µl TEA. After stirring at room temperature overnight, the product was kept at room
temperature for later use. The concentration of PS-b-PSMANTA obtained in the end was
about 120 mg/mL. One portion of the solution was dialyzed against DI water and recovered
by freeze drying for NMR and FT-IR characterizations. The polymer was named as PS-bPSMANTA.
3.2.5 Preparation of PS-b-PSMANTANi. The micelles were prepared by dropwise
adding 50 µL (6 mg) of PS-b-PSMANTA solution from the previous step to 3 mL of pH
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8.0, 50 mM Tris-HCl buffer under vigorous stirring at room temperature. Then 5 µmol of
NiSO4 was added and the solution was stirred for 2 hr. DMF, TEA and excess Ni 2+ was
removed by dialysis against Tris-HCl buffer for 48 hr with buffer exchange up to 6 times.
The size and morphology of micelles were characterized by DLS and TEM.
3.2.6 Expression and purification of 6×His-tagged fluorescent protein mcherry and
eGFP. The E. Coli strain DH5α was used as host for genetic manipulation. The genes of
mcherry and eGFP were PCR amplified from the plasmid pET28-keap1mcherry and
pET28-eGFPNrf2, respectively. They shared the same forward primer 5’-CGC GCG GCA
GCC ATA TGA TGG TGA GCA-3’, but different reverse primers, 5’-CAA GCT TGT
CGA CGG AGC TCC TAC TTG TAC AGC TCG TCC ATG-3’ for mcherry and 5’-CAA
GCT TGT CGA CGG AGC TCT TAT CTA-3’ for eGFP. The PCR products were digested
and ligated into NdeⅠ and SacⅠ digested pET28a vector to construct plasmids pET28mcherry and pET28-eGFP.
The E. Coli strain Rosetta2 (DE3) was used for the expression of both mcherry and
eGFP. Cells were precultured overnight at 37 ℃ in LB medium supplemented with 50
µg/mL of kanamycin. The preculture were subinoculated when the OD600 reached between
0.6-0.8. Cells were cooled down to 25 ℃ and induced by 300 µM of IPTG. After 4 hr
culture, cells were harvested by centrifugation (5,000 × g, 15 min) at 4 ℃, then washed by
pH 8.0, 50 mM, Tris-HCl buffer and centrifuged again to get the pellet.
The harvested cells were suspended in binding buffer (pH 8.0, 50 mM Tris-HCl, 100
mM NaCl, 5 mM imidazole) and lysed with a sonicator. Cell lysate was centrifuged at
10,000 × g, 20 min, 4 ℃, and the supernatant was filter by 0.22 µm membrane and loaded
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on HistrapTM column. Proteins were eluted by elution buffer (pH 8.0, 50 mM Tris-HCl,
100 mM NaCl, 150 mM imidazole) then dialyzed against pH 8.0, 50 mM Tris-HCl buffer,
aliquoted, and stored at -80℃.
The concentration of fluorescent proteins was measured by UV-vis. The extinction
coefficient of mcherry is 72,000 M-1cm-1 at 587 nm and eGFP is 56,000 M-1cm-1 at 488
nm.
3.2.7 Assembly of PS-b-PSMANTANi with different proteins. The concentration of
NTANi moieties in the prepared micelle was about 0.82 mM. Based on this concentration,
the moles of protein assembled with the micelle was also calculated. The molar ratio of
NTANi to fluorescent protein was 10:1, and the molar ratios of NTANi to cellulases were
controlled as 0:1, 5:1, 10:1, and 20:1, respectively. The buffer for the assembly process
was pH 8.0, 50 mM Tris-HCl buffer unless otherwise mentioned. Various concentrations
of micelles were prepared, and the protein solution was then added and gently mixed. The
mixture was incubated at 4 oC and assembled overnight.
3.2.8. Enzymatic activity assay. Cellulose hydrolysis reactions were performed in pH 8.0,
50 mM Tris-HCl buffer with 0.1% of phosphoric-acid-swollen-cellulose (PASC).
Reactions were performed at 37 °C and 200 µL of samples were collected periodically and
immediately mixed with 600 µL of DNS reagents (10 g/L dinitrosalicylic acid, 10 g/L
sodium hydroxide, 2 g/L phenol, 0.5 g/L sodium sulfite). After incubating at 95 °C for 10
min, 200 µL of 40% Rochelle salts (potassium sodium tartrate) was added to fix the color
before reading the UV-vis absorbance of the supernatants at 575 nm.
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3.3 RESULTS AND DISCUSSION
3.3.1 Preparation of NTA modified PS-b-PSMA. The preparation of PS-b-PSMA by
RAFT polymerization has been well explored and the synthesis scheme is shown below
(Scheme 3.1). 5-7
Scheme 3.1 The preparation of PS-b-PSMANTANi.

Previous studies have reported one-step and two-step methods for the preparation of
PSMA type of polymers.

5-6

As reported by Wooley group, a block of alternating

copolymers (PSMA) could be formed regardless of the St/MA charging ratios. 7 After the
complete consumption of MA, the PSMA chains will continue to extend a
homopolystyrene block to have PS-b-PSMA. The ratio of St/MA/CTA/AIBN is chosen as
200/20/1/0.4. The final conversion of styrene was 70% based on 1H NMR characterization
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(using 1,4-dioxane as the internal standard). The theoretical molecular structure is denoted
as PS120-b-P(St-alt-MA)20, which has an average molecular weight of 16520 g/mol. The
polymer was characterized by 1H NMR (Figure 3.1A) and GPC (Figure 3.1B). As shown
in Figure 3.1A, the broad peak from 6.2-7.4 ppm is from the protons on the aromatic rings
and the peak from 1.2-2.0 ppm is from the protons on the backbone. The number average
molecular weight of the polymer is determined to be 13900 g/mol with Đ=1.21 by GPC,
confirming the narrow dispersity of the polymer. DSC characterization (Figure 3.1C)
showed two distinct glass transition temperatures at 104 oC and 140 oC, supporting that the
final product has a blocky structure.
PS-b-PSMA was subsequently modified with amino-NTA. The ratio of amino-NTA to
the anhydride group is about 0.38:1. The incorporation of NTA groups to PS-b-PSMA can
increase the hydrophilicity of the PSMA block and make the resultant polymer an
amphiphilic diblock copolymers. The product was characterized by 1H NMR (Figure
3.1A) and FT-IR (Figure 3.1D). As shown in the spectrum of the modified polymer, a
characteristic peak is shown at 3.0 ppm, representing the methylene protons next to the
amide groups. The infrared spectra of PS-b-PSMA showed the presence of anhydride peaks
at 1776 and 1854 cm-1. The characteristic absorption peak for carboxylic acid at 1725 cm1

from PS-b-PSMANTA confirmed the hydrolysis of anhydride and the successful

modification of PS-b-PSMA.
3.3.2 Preparation of PS-b-PSMANTANi micelles. As mentioned above, the NTA
modified PSMA block is hydrophilic and the PS block is hydrophobic, this amphiphilic
struc makes it possible to form micelles in aqueous solution through self-assembly. In our
study, the PS-b-PSMANTA solution was added dropwise to Tris-HCl buffer under stirring
62

Figure 3.1 Characterization of PS-b-PSMA and PS-b-PSMANTA: 1H NMR of PS-bPSMA and PS-b-PSMANTA (A), GPC characterization of PS-b-PSMA (B), DSC
characterization of PS-b-PSMA (C) and FT-IR spectra of PS-b-PSMA and PS-bPSMANTA (D).
and NiSO4 was then added to the mixture. The NTA moiety has strong affinity with Ni2+
ions to form stable NTANi complex. After 2 hr stirring, the mixture was dialyzed against
Tris-HCl buffer to remove organic solvent and excess Ni 2+ ions. The size and morphology
of the micelles were characterized by DLS and TEM. The DLS showed that the average
size of the PS-b-PSMA micelles was around 20 nm (Figure 3.2A). The micelles were
negatively stained by 2% PTA and observed by TEM, showing spherical micelles with size
of around 20 to 30 nm which is consistent with DLS results (Figure 3.2B). These particles
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have rigid PS core and a shell layer with NTANi complexes which are able to capture
6×His-tagged proteins and can serve as a platform for constructing new polymer-protein
nanomaterials.

Figure 3.2 DLS (A) and TEM (B) characterization of PS-b-PSMANTANi nanoparticles.
3.3.3 Assembly of PS-b-PSMANTANi with fluorescent protein. To prove the capability
of PS-b-PSMANTANi particles to capture 6×His-tagged proteins, we did a model study
using 6×His-tagged fluorescent proteins. These proteins will incorporate fluorescent
properties to the nanoparticles and provide a direct proof for the assembly process between
the nanoparticle and proteins.
The genes of mcherry and eGFP were cloned in pET28 vector (pET28-mcherry and
pET28-eGFP) and expressed in Rosetta2(DE3) cells. The purified proteins were tested by
SDS-PAGE (Figure 3.3A). We first chose mcherry to assemble with of PS-bPSMANTANi particles. The molar ratio of NTANi to protein was 10:1. The molecular
weight of mcherry is around 29 kD and the self-assembled PS-b-PSMANTANi micelles
has much higher molecular weight than theoretical calculated value 16520 D, since it will
take multiple polymer chains to form a nanoparticle. The high molecular weight of a
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nanoparticle makes it possible to characterize the elution volume of pure micelles, pure
mcherry, and assembled PS-b-PSMANTANi-mcherry by FPLC (Figure 3.3B). Three
wavelengths were monitored, 254 nm, 280 nm and 587 nm. The styrene groups have a
maximum absorption at 254 nm, and the mcherry protein has absorption peaks at 254 nm,
280 nm and 587 nm, respectively. From the FPLC results, the 254 nm absorption peak
indicated that the elution volume of bare micelles was ~ 9 mL, and the 587 nm absorption
peak implied the elution volume of mcherry was at ~ 16.5 mL. After the assembly of the
bare nanoparticles and mcherry, the 254 nm and 587 nm absorption peak shifted, and the
major peak of elution volume was decreased to ~ 7 mL, indicating a bigger size of the
resultant assemblies as compared to the bare particles. Also, the 254 nm and 587 nm
absorption peaks overlap with each other very well, indicating that mcherry was anchored
on the particles. All these results proved that PS-b-PSMANTANi micelles have the
capability to capture 6×His-tagged proteins.

Figure 3.3 (A), SDS-PAGE of purified mcherry and eGFP; (B), FPLC chromatographs of
PS-b-PSMANTANi, mcherry and PS-b-PSMANTANi-mcherry.
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Fluorescent protein-based Förster or fluorescence resonance energy transfer (FRET) is
a powerful method for detecting protein-protein interactions and biochemical reactions in
living cells. 8-10 The mcherry and eGFP are FRET pair because there is overlap of the donor
eGFP fluorescent emission spectrum with the acceptor mcherry excitation spectrum. Here,
a mixture of mcherry and eGFP was used to assemble with PS-b-PSMANTANi micelles.
We expected that the assembled proteins have closer proximity (<10 nm) and there will be
FRET from the assembled nanocomplexes. The molar ratio of mcherry to eGFP was
controlled at 1:1, and the molar ratio of NTANi to total protein moles was 10:1. Three
groups of control experiments were set up: micelles and mcherry; micelles and eGFP; the
free mcherry and eGFP mixture. The protein final concentration for either mcherry or eGFP
was the same in the FRET study group.

Figure 3.4 FRET study of PS-b-PSMANTANi and fluorescent protein assembly. The red
arrows indicate the change of fluorescent intensities.
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From the experimental group, a decreased emission at ~ 510 nm from eGFP and an
increased emission at ~ 610 nm from mcherry were observed as compared to the control
groups (Figure 3.4). This indicates that the assembled eGFP and mcherry are within very
close distance to each other on the particle surface.
3.3.4 Assembly of PS-b-PSMANTANi with cellulases. In chapter 2, we investigated the
activity of cellulases on CSNPs with different protein to polymer ratios and found that they
didn’t show elevated activity. This might be attributed to the randomness of the proteins
display on the corona of CSNPs, thus not all activity centers are exposed to substrate.
Therefore, using the high affinity binding between NTANi and polyhistidine, we expected
to immobilize 6×His-tagged cellulases on the micelles’ surface with defined orientation.
We hypothesize that the assembled cellulases would have closer proximity and show
enhanced activity in cellulose hydrolysis.
We first assembled CelA and CelF with PS-b-PSMANTANi, respectively. The molar
ratio of NTANi to cellulase was 20:1. The assembled particles were characterized by DLS,
TEM and FPLC. From DLS results, the average size of the particles of PS-bPSMANTANi-CelA was 38 nm and PS-b-PSMANTANi-CelF was 41 nm, which are
bigger than bare PS-b-PSMANTANi particle. A representative TEM image of PS-bPSMANTANi-CelA shows that after assembly the particles are still spherical and their size
is around 40 nm (Figure 3.5B). FPLC was used to characterize the PS-b-PSMANTANiCelA (Figure 3.5C). Two wavelengths were monitored, i.e. 254 nm and 280 nm. The
styrene groups have a maximum absorption at 254 nm. The CelA protein has absorption
peaks at 254 nm and 280 nm, respectively. The elution volume of the PS-b-PSMANTANiCelA was at ~ 7.5 mL, smaller than bare PS-b-PSMANTANi and CelA, which means that
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the assembled particles have bigger size. Also, the 280 nm absorption intensity increased
at elution volume of 7.5 mL and this indicated that CelA was anchored on the particle
surface.
We also assembled the protein mixture of CelA and CelF with PS-b-PSMANTANi. The
molar ratio of CelA to CelF was 1:1, and the molar ratios of NTANi to cellulases mixture
were 0:1, 5:1, 10:1 and 20:1, respectively. Compared to bare micelles, the average size of
particles has increased to 49 nm (5:1), 47 nm (10:1) and 45 nm (20:1) upon assembly
(Figure 3.5A).

Figure 3.5 (A) DLS analysis of particles PS-b-PSMANTANi-CelA, PS-b-PSMANTANiCelF, and PS-b-PSMANTANi-Cel with different molar ratios of NTANi to Cel, 5:1, 10:1
and 20:1; (B), TEM image of PS-b-PSMANTANi-CelA, scale bar represents 100 nm; (C),
FPLC analysis of PS-b-PSMANTANi, CelA and PS-b-PSMANTANi-CelA.
To check the enzyme activity, the 0.1% PASC prepared from Sigmacell according to
the method of Walseth was used as substrate.
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11

The reducing sugars produced by

assembled mono-enzyme were first compared with free ones by DNS method. As shown
in Figure 3.6, the assembled CelA (1 µM) produced about more than two-fold of reducing
sugar than free CelA after 4 hr measurement, and so did the assembled CelF after 24 hr.

Reducing Sugar (mg/L)

100
80

4 hr, free
4 hr, assembled
24 hr, free
24 hr, assembled

60
40
20
0
CelA

CelF

Figure 3.6 Catalytic activity test of (A) 1 µM free CelA and 1 µM assembled CelA (left);
1 µM free CelF and 1 µM assembled CelF (right). The molar ratio of NTANi to Cel was
20:1.
We also measured the reducing sugar produced from the assembled CelA&CelF
mixture. In Figure 3.7A, at the 4 hr time point, the groups with PS-b-PSMANTANi
particles (5:1, 10:1, 20:1) exhibited a slightly higher level of reducing sugar as compared
to free cellulase (0:1). After 24 hr of incubation, obvious difference was observed. The
experimental groups (5:1, 10:1, 20:1) gave reducing sugar levels of 1.5, 1.6, and 1.4 times
of the control group (0:1). The optimal result was from the group 10:1. Interestingly, higher
level of NTANi groups (20:1) leads to lower catalytic efficiency, possibly due to the
increased spacing between the immobilized enzymes. Similar results were also observed
with a fixed cellulase concentration of 2 µM (Figure 3.7B). This demonstrated that the
enhanced activity of cellulases immobilized on PS-b-PSMANTANi surface is due to
proximity effect.
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Figure 3.7 Enzyme assays by DNS method of (A) 1 µM free CelA&CelF mixture and 1
µM co-assembled CelA&CelF; (B) 2 µM free CelA&CelF mixture and 2 µM co-assembled
CelA&CelF. The CelA to CelF molar ratio was 1:1. The NTANi to Cel molar ratio includes
0:1, 5:1, 10:1 and 20:1.
In native cellulosome, multiple types of cellulases are assembled together by the highaffinity docker-cohesin interaction, resulting in the substrate channeling between different
enzymes. Therefore, the high efficiency of cellulose hydrolysis is also due to the synergy
effect. 12-14 We compared the reducing sugar released from 1 µM cellulase concentration
with NTANi to Cel molar ratio of 20:1. As shown in Figure 3.8, the reducing sugar
produced at 24 hr was about 50 mg/L from the assembled CelA and 38 mg/L from the
assembled CelF. As a comparison, the reducing sugar produced by the 1 µM of CelA&CelF
co-assembled complex at 24 hr was about 106 mg/L from group 20:1, which was more
than double than either CelA or CelF individually. At a ratio of 10:1 of NTANi to Cel, the
total amount of reducing sugar produced from assembled mono-enzyme CelA and CelF
was around 88 mg/L, while those from the assembled CelA&CelF mixture was about 193
mg/L. Again, it shows that the co-assembly of CelA and CelF is essential to achieve higher
catalytic activity and the increase of released reducing sugar is because of both proximity
effect and synergy effect.
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Figure 3.8 Activity comparison of (A) assembled 1 µM CelA with NTANi to protein molar
ratio at 20:1; (B) assembled 1 µM CelF with NTANi to CelF molar ratio at 20:1; (C) coassembled 0.5 µM CelA & 0.5 µM CelF with molar ratio of NTANi to Cel 20:1; (D) coassembled 1 µM CelA & 1 µM CelF with molar ratio of NTANi to Cel 10:1.
In another study, 6×His-tagged arylamine N-oxygenase CmlI, which has no cellulose
hydrolysis activity, is used as a “stealth protein” to replace CelF or CelA during the
assembly process. This study will help us to compare the catalytic efficiency of a single
enzyme with different particle surface coverages. The concentration of each protein was
kept at 1 µM and the molar ratio of NTANi to protein was kept at 10:1. As shown in Figure
3.9A, when the molar ratio of NTANi to protein was 10:1 and Cel concentration was1 µM,
the reducing sugar produced at 24 hr was 52 mg/L from the assembled CelA&CmlI and 33
mg/L from the assembled CelF&CmlI. As a comparison (Figure 3.9B), with same Cel
concentration but NTANi to protein was 20:1, the reducing sugar produced was similar,
about 50 mg/L from the assembled CelA and 38 mg/L from the assembled CelF. This
proves that the surface coverage has no impact on cellulase activity.
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Figure 3.9 (A) Co-assembled 1 µM CelA & 1 µM CmlI (left) and co-assembled 1 µM
CelF & 1 µM CmlI (right); (B) comparison of CelA and CelA&CmlI, CelF and
CelF&CmlI.
In the enzymatic assay, we noticed that the single enzyme activity of CelA is higher than
CelF which has native CBD domain. This might be because the substrate used was PASC,
which has the majority of the crystalline regions of the cellulose converted to amorphous
domains. At high concentration of accessible sites, the mobility of the enzymes is a critical
factor for reaching maximum activity. 15 After assembly, CelA and CelF were brought in
close proximity and the CBD from CelF could assist the binding of cellulase to the
crystalline region of substrate, which could be further benefit to substrate channeling and
achieve more efficient cellulose hydrolysis by synergy effect.
3.4 CONCLUSIONS
In this chapter, polymeric nanoparticles with exposed NTANi moieties were prepared to
capture cellulases for enhanced catalytic activity in hydrolyzing cellulose. PS-b-PSMA
was prepared through RAFT polymerization in a one-pot method. The anhydride groups in
the PSMA block were partially reacted with amino-NTA to make amphiphilic block
copolymers. The self-assembly of the NTA modified polymer in the presence of Ni2+ ions
led to form nanoparticles of about 20 nm in aqueous solution. The NTANi complexes
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presenting on the particle surface can capture 6× His-tagged proteins by strong affinity
binding. The conjugated proteins mcherry and eGFP are within close proximity and the
FRET effect between them was detected. The catalytic activity of assembled cellulases was
elevated after assembled with NTANi containing micelles which can be attributed to the
enhanced local concentration and synergy effect.
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CHAPTER 4 MODIFICATION OF TOBACCO MOSAIC VIRUS FOR PROTEIN
IMMOBILIZATION
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4.1 INTRODUCRION
Viruses and virus-like nanoparticles (VNP) have been extensively studied for the formation
of hybrid biomaterials and widely applied in biomedical field.

1-6

Tobacco mosaic virus

(TMV), as a classic virus model, is rod-shaped and highly ordered, 300 nm in length and
18 nm in diameter, consisting of 2130 identical subunit proteins arranged helically around
a genomic single RNA strand.

7

The interior and exterior surfaces of TMV can be both

chemically and genetically ornamented with functional groups to afford new properties for
various applications. 7-12
It has been found that the Tyr139 residue is a particularly attractive target for
chemoselective modification of TMV due to its abundant distribution. 8 Previous studies
in our group have reported that a wide array of starting materials can be conjugated to
Tyr139 by the sequential diazonium-coupling and Cu(Ⅰ)-catalyzed azide-alkyne 1,3dipolar cycloaddition (CuAAC) reaction. 12 For example, TMV has been modified with a
PEG chain to link pyrene (PYR) moiety, consequently fabricating an electron-donor based
on VNPs.

13

The modified fluorescent TMV-PYR can form supra-amphiphiles with

different electron-deficient molecules through charge transfer interactions. In another
study, TMV was used as a carrier for the display of small molecule estriol (E3), a weakly
immunogenic hapten, through different linkers and to display E3 units in controllable
density. 14 It has been found that E3 displayed in high density could induce a stronger and
longer-term antibody response.
In this chapter, we are aiming to modify TMV Tyr139 residue with NTA groups. As
well known that the polyhistidine has high affinity with NTANi and has been widely used
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for protein purification. Here, through this specific interaction, we want to use NTANi
modified TMV as a platform for 6×His-tagged functional protein immobilization.
4.2 MATERIALS AND METHODS
4.2.1. Materials. 3-Bromopropionic acid, 1,3-dicyclohexylcarbodiimide (DCC), Nhydroxysuccinimide esters (NHS), triethylamine (TEA), p-toluenesulfonyl chloride,
sodium

azide

(NaN3),

3-aminophenylacetylene,

(CuSO4·5H2O),

sodium

ascorbate

(NaAsc),

copper

sulfate

pentahydrate

tris[2-(dimethylamino)ethyl]amine

(Me6TREN), (S)-N-(5-amino-1-carboxypentyl)iminodiacetic acid (amino-NTA), and
other chemicals were local commercial products and used as received. All organic solvents
were dried and distilled before used.
4.2.2. Characterization. UV-Vis spectra were acquired on NanoDrop™ 2000c
spectrophotometer; fluorescence spectra were measured on Varian Cary Eclipse
spectrometers; Matrix-assisted laser desorption/ionization time of flight mass spectrometry
(MALDI-TOF MS) analysis was performed using a Bruker Ultraflex I TOF/TOF mass
spectrometer, for sample preparation: followed the procedure from the IMCStips TM;
transmission electron microscopy (TEM) measurements were carried out on a Hitachi
H8000 electron microscopy operating at an acceleration voltage of 200 kV, for sample
preparation: about 20 µL of aqueous solution was dropped on the carbon-coated copper
grid and negatively stained with 10 µL 2% of phosphotungstic acid (PTA); NMR spectra
were characterized on a Varian Mercury 300/400 apparatus spectrometer using CDCl3 as
solvent; Fast protein liquid chromatography (FPLC) analysis was performed on AKTA
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explorer (GE Biotech) using Superose 6 10/300 GL column with the flow rate of 0.5
mL/min; dynamic light scattering (DLS) was performed by Malvern Zetasizer Nano-ZS.
4.2.3. Synthesis of N3-NTA. The 3-azido-1-propionic acid (APrA) was synthesized via a
previous reported method.

15

First, 3-bromopropionic acid (4.0 g, 26.1 mmol) was

dissolved in a mixture of 20 mL DMF and 20 mL of DI H2O. NaN3 (1.9 g, 29.1 mmol) was
added to the solution. The mixture was stirred at 55 ℃ for 18 hr and 67 ℃ for 6 hr before
cooling down to room temperature. The crude solution was extracted 100 mL of diethyl
ether for 3 times. The combined organic phase was washed with saturated sodium chloride
solution. After drying with magnesium sulfate and evaporation of the solvent, a color less
oil product AprA was obtained.
The acid group of APrA was activated by forming 3-azidopropanoate-Nhydroxysuccinimide ester (APrANHS). 16 4.0 mmol of AprA and 4.0 mmol of NHS were
dissolved in 5 mL dry dichloromethane (DCM). 4.0 mmol of DCC dissolved in 5 mL of
dry DCM was dropwise added to the reactant mixture. The reaction was carried out at 4 ℃
for 4 hr, then at room temperature for 12 hr. The crude product was washed by 10 mL of
saturated ammonium chloride solution and extracted by 10 mL of DCM. The organic phase
was saved then dried by anhydrous magnesium sulfate. After filtration, DCM was removed
by rotovap. The product APrANHS was white solid with a little light-yellow oil.
Azido group modified nitrilotriacetic acid (AzoNTA) was obtained by reacting
APrANHS with (S)-N-(5-Amino-1-carboxypentyl)iminodiacetic acid (aminoNTA).
APrANHS (0.4 mmol) was firstly dissolved in 1 mL of dimethyl sulfoxide (DMSO), then
aminoNTA (0.4 mmol) and 15 µL of trimethylamine were added. The mixture was stirred
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at room temperature overnight. The crude product azido-NTA was checked by FTIR and
stored in 4 oC for later use.
4.2.4. TMV-alkyne. The wild type TMV (TMV-wt) was purified from infected tobacco
leaves according to established protocols described elsewhere.

17-18

The modification of

TMV with alkyne group was performed via diazonium coupling reaction. 8
4.2.5. TMV-NTANi.
The NTA modified TMV (TMV-NTA), was prepared by CuAAC reaction. Briefly, 2 mL
of TMV-alkyne (5 mg/mL) of and 40 µL (about 4 mg) of AzoNTA was sequentially added
to 2.1 mL of 20 mM pH 8.0 Tris-HCl buffer. Then, the mixture of 80 µL of 0.1M CuSO4
and 21 µL (80 µmol) of Me6TREN dissolved in 0.7 mL of DMSO was added. Last, 120
µL of 0.2 M sodium ascorbate was added. The reaction was conducted at room temperature
for 18 hr and the product TMV-NTA was purified by ultracentrifuge with 40% sucrose
cushion at 40000 rpm/50.2 Ti for 2.5 hr at 4 ℃. The pellet was suspended with 50 mM,
pH 8.0 Tris-HCl buffer. Bradford protein assay kit was employed to measure the TMVNTA concentration. The modification was identified by SDS-PAGE and MALDI-TOF.
The virus integrity was confirmed by TEM and FPLC.
The TMV-NTANi was prepared by adding NiSO4 to the TMV-NTA solution. The molar
ratio of Ni2+ to NTA was 20: 1. Excess Ni2+ was removed by dialysis against 50 mM pH
8.0 Tris-HCl buffer.
4.2.4. Assembly of TMV-NTANi and protein. Fluorescent protein 6×His-tagged mcherry
and eGFP were used as model protein to assembly with TMV-NTANi. The concentration
of fluorescent proteins was measured by UV-vis and calculated by using extinction
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coefficient ε=56,000 M-1cm-1 for eGFP and ε=72,000 M-1cm-1 for mcherry. The
concentration of NTANi was converted from the mole of TMV (MW= 39 × 10 6 kD). The
buffer solution for the assembly process was 50 mM pH 8.0 Tris-HCl with 100 mM NaCl.
The molar ratio of fluorescent protein to NTANi was 1:1.
4.3 RESULTS AND DISCUSSION
4.3.1 Synthesis of TMV-NTANi. The chemistry on the surface of TMV provides a great
possibility for modifications. The current work is to explore a method for immobilizing
proteins on the surface of TMV. This type of materials might exhibit properties benefiting
from the special TMV morphology and the immobilized proteins. Our strategy is to
introduce NTA group to the exterior surface of TMV-wt and immobilize 6×His-tagged
proteins through the strong interaction between 6×His-tag and NTANi. The proteins will
be oriented on TMV surface.
The NTA group was attached to the exterior surface of TMV(wt) by the sequential
diazonium-coupling and Cu(Ⅰ)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction as
shown in Scheme 4.1.
To introduce azido group to the amino-NTA, the bromo group of 3-bromopropionic was
converted to azide by sodium azide before activating its carboxylic acid group by forming
NHS ester. As shown in Figure 4.1, peaks at 2.57-2.59 ppm (2H, -CH2COOH) and 3.513.53 ppm (2H, -CH2N3) were observed for AprA. Also, peaks at 3.59-3.64 (2H, 2H, CH2N3) and 2.75-2.81 (6H, -CH2CO-) proved the preparation of AprANHS.
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Scheme 4.1. The synthesis scheme of TMV-NTANi.
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Figure 4.1 The 1H NMR spectra of AprA (A) and AprANHS (B).
The AzoNTA was produced by AprANHS reacting with aminoNTA, and it was used
for further reaction without purification. The IR spectra of AprANHS and AzoNTA was
compared (Figure 4.2). The peak at 1713 cm-1 shows the presence of carboxylic acid
groups from AzoNTA, and the 1665 cm-1 demonstrates the amide bond formation.
The diazonium salt was prepared from 3-aminophenylacetylene in the presence of
sodium nitrite and p-toluenesulfonic acid. During the reaction, the color changed from clear
to yellow indicating the formation of diazo bond. The diazonium salt was reacted with
TMV-wt in basic condition (borate buffer, pH 9.0) to generate TMV-alkyne. The product
was separated from unreacted salt by 40% (w/w) sucrose gradient ultracentrifugation. The
pellet was suspended in Tris-HCl buffer and used for the CuAAC reaction with AzoNTA
to produce TMV-NTA. The ligand Me6TREN in this step is essential. Without Me 6TREN,
the Cu2+ would chelate with NTA moieties and lose its catalytic function. The TMV-NTA
was also purified by 40% (w/w) sucrose gradient ultracentrifugation to remove small
molecules. After suspending the pellet, the NiSO4 was added to TMV-NTA solution and
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excess ions were removed by dialysis.

Figure 4.2 The FT-IR spectra of AprANHS (black curve) and AzoNTA (red curve).
The final product was characterized by UV-vis, SDS-PAGE and MALDI-TOF MS
(Figure 4.3). The UV-vis absorption at 325 nm confirmed the presence of diazo bond in
TMV-alkyne and TMV-NTA. The 15% SDS-PAGE was utilized to characterize the
modification. Comparing with the TMV-wt, the band of TMV-alkyne showed higher
molecular weight. The TMV-NTA showed one major band which has the highest
molecular weight and another faint band in the lane. Using ImageJ, we analyzed those two
bands. It showed that about 80% of TMV-alkyne has been modified with NTA moiety.
From the MALDI-TOF MS analysis, the peak disappearance at m/z 17534 (TMV-wt) and
appearance at m/z 17662 (TMV-alkyne) was a direct evidence for the complete
incorporation of alkyne group. The TMV-NTA showed a broad peak which means the
incomplete conversion from TMV-alkyne.
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Figure 4.3 The characterization of TMV modification by UV-vis (A), SDS-PAGE (B) and
(C) MALDI-TOF MS of TMV-wt (MW, 17534 D), TMV-alkyne (MW, 17662 D) and
TMV-NTA (MW, 18020 D).
The integrity of the virus particles was verified by DLS and FPLC (Figure 4.4). After
modification, TMV-alkyne, TMV-NTA and TMV-NTANi all showed same size
distribution as the TMV-wt. The same elution volume of TMV-wt, TMV-alkyne and TMVNTANi in FPLC analysis implied that the integrity of virus was retained.

Figure 4.4 DLS (A) and FPLC (B) analysis of TMV and its derivatives.
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4.3.2 The assembly of TMV-NTANi with 6×His-tagged fluorescent proteins.
Fluorescent proteins eGFP and mcherry with 6×His-tag are employed as models to test the
ability of TMV-NTANi to immobilize proteins. The molar ratio of protein to NTANi was
1:1. The mcherry and eGFP assembled with TMV-NTANi respectively. Their mixture was
also assembled with TMV-NTANi. The assembled samples were analyzed by FPLC. Three
UV-vis wavelength 325 nm, 488 nm and 587 nm were tracked to indicate the elution
volume and elution components of TMV-NTANi, eGFP and mcherry, respectively. As
shown in Figure 4.5, the elution volume of unassembled free eGFP is about 16 mL.
However, eGFP can be eluted at the same time with TMV-NTANi if they assembled and
the elution volume decreased to about 6.5 mL from the tracking of the characteristic UVvis absorbance of eGFP at 488 nm. Similar phenomenon was observed for mcherry, the
characteristic absorbance of mcherry at 587 nm and the TMV-NTANi absorbance at 325
nm were detected at the same elution volume. Integration of peak area analysis indicated
that about 76% of mcherry and 82% of eGFP has been captured by NTANi. The mixture
of eGFP and mcherry with same molar ratio was also used to assemble with TMV-NTANi.
Three wavelengths representing TMV-NTANi, eGFP and mcherry were detected at the
same elution volume. The UV-vis measurement of the eluted fraction showed that the
characteristic peaks of 488 nm and 587 nm were detected. This further confirmed us that
TMV-NTANi can assemble with 6×His-tagged protein. The TEM image of TMV-NTANieGFP-mcherry (Figure 4.6) showed that after assembly the TMV particles still retain the
integrity.
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Figure 4.5 FPLC analysis for free eGFP (A) and TMV-NTA-eGFP (B), mcherry (C) and TMV-NTANi-mcherry (D), TMV-NTANieGFP-mcherry (E) and UV-vis measurement of assembled samples (F).

Figure 4.6 TEM image of TMV-wt (A) and TMV-NTANi-eGFP-mcherry (B). Scale bars
represent 100 nm.
4.4 CONCLUSIONS
In this chapter, the surface of cylindrical shaped TMV was modified with NTANi groups.
This modified VNPs can serve as a new platform for constructing novel biomaterials
through the specific interaction between NTANi complexes and 6×Hig-tagged proteins.
Our current work employed two fluorescent proteins, eGFP and mcherry, as model proteins
to study to potential of TMV-NTANi for protein immobilization. It was shown that eGFP
and mcherry can be immobilized separately or together on TMV surface. We believe that
this method can be extended to other 6×his-tagged functional proteins, for example, the
cellulases used in the previous chapter.
It has been reported that the distance between TMV coat protein subunit is in 5 nm,
therefore, in future work, we should investigate the proximity of enzymes captured on
TMV-NTANi surface. The mcherry and eGFP fluorescent proteins can be used for the
study because they are good FRET pair. If the immobilized enzymes have close proximity,
TMV-NTANi would be an ideal carrier for the artificial cellulosome construction.
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